Should I buy Healthcare Realty Trust (HR) stock or is it too late?

Healthcare Realty Trust · Real Estate · price $19

See the full Healthcare Realty Trust (HR) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Cantor Fitzgerald — 63% of its targets hit on this sector (8 calls tested). It aims for $24 (+26 %), call made on August 1, 2026, maturing on August 1, 2027 (27 d ago).

The 4 reliable analysts $21.50+12 %

The 3 other firms $21+9.8 %

How to read it: the 4 reliable firms are not filtered by optimism — 4 aim above the price, 0 below, hence their $21.50 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

In short — Should you invest in Healthcare Realty Trust? Is it too late, still worth it? Analysts are split (29% buy, median target $21, i.e. +10%), and the most reliable on HR targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $21, i.e. +10% from the current price ($19).
The most reliable firm on HR, JP Morgan (100% hit rate, 2 scored calls), targets $21 (call made on July 9, 2026, maturing on July 9, 2027) (+10%) in its most recent call.
Pays a dividend (4.7% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 7 ratings, 5 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on HR

Median target $21 (+10%) · 7 ratings · Hold consensus

Strong Buy00%

Buy229%

Hold571%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Healthcare Realty Trust now?

We won't decide for you. The facts: 29% of analysts rate it a buy, median target $21 (+10%), and JP Morgan (most reliable on HR, 100%) targets $21. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Healthcare Realty Trust?

Not according to analysts: the median target ($21) is still +10% above the current price ($19) (most reliable on HR: JP Morgan, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Healthcare Realty Trust still worth investing in?

It depends on the gap between the price ($19) and its estimated value: analysts target $21 on median (+10%), with 29% buys (most reliable on HR: JP Morgan, 100%). Cross-check with their real reliability on HR and the cautions above. Information, not advice.

What's the main risk in buying HR?

The consensus is not unanimous: of 7 ratings, 5 are neutral.

→ Go deeper: the full Healthcare Realty Trust profile (consensus, analyst reliability, price target, performance).